Research finds cancer risk remains after hormone therapy

A Women's Health Initiative study showed that almost all benefits of hormone therapy for menopause disappeared after therapy ended, but a slightly elevated risk of breast and other cancers persisted for at least three years. The study's investigators cautioned against alarm over the findings, saying that the increased risk for cancer was fairly small.

View Full Article in:

ClipSyndicate · NYTimes.com · Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC